In severe COVID-19, deregulated complement activation enhances the recruitment of neutrophils to the infected lungs and promotes tissue factor (TF) expression on neutrophils, monocytes, and endothelial cells, resulting in microvascular thrombosis and endothelial dysfunction [1,3,4]. Here, TF is linked to COVID-19.